December 21, 2025 a 09:00 am

HSIC: Analyst Ratings - Henry Schein, Inc.

Henry Schein, Inc. stock analysis

The current analyst sentiment for Henry Schein, Inc. (HSIC) indicates a balanced outlook with a mix of recommendations. The company, operating globally in the healthcare products and services sector, continues to maintain a strong position in the market. However, the prevalence of 'Hold' ratings suggests a cautious approach among analysts. Investors will need to consider both the growth potential and the inherent risks in this sector.

Historical Stock Grades

The latest analyst recommendations for HSIC, as of December 1, 2025, show a trend leaning towards caution, with 'Hold' being the most prominent recommendation. The following table highlights the current distribution of analyst ratings:

Recommendation Count Score Bar
Strong Buy 4
Buy 2
Hold 9
Sell 1
Strong Sell 0
Image showing analyst ratings history for Henry Schein, Inc. Stock chart for Henry Schein, Inc.

Sentiment Development

The sentiment for Henry Schein, Inc. has shown stability over recent months with a consistent hold on 'Hold' ratings. Despite some fluctuations in 'Strong Buy' recommendations, the overall sentiment remains cautious with a steady 'Hold' category presence.

  • The total number of ratings has remained fairly stable, hovering around similar values each month.
  • 'Strong Buy' ratings saw a minor increase towards the end of 2025, indicating a slight positive shift in sentiment.
  • 'Hold' ratings continue to dominate, reflecting a balanced stance by analysts.
  • A minor decline in 'Buy' ratings suggests cautious optimism among analysts.

Percentage Trends

Analyzing the percentage trends over recent months shows an insightful shift in the composition of analyst recommendations for Henry Schein, Inc. Overall, there's been a slight movement from 'Buy' towards 'Hold' and 'Strong Buy'.

  • Percentage of 'Strong Buy' increased from 2024 to late 2025, showing growing confidence in the stock.
  • 'Buy' recommendations slightly decreased, indicating some caution among bullish analysts.
  • 'Hold' ratings consistently remain the largest portion, reflecting ongoing uncertainty or a balanced outlook.
  • A decrease in 'Sell' and 'Strong Sell' ratings reveals a more positive outlook.

Latest Analyst Recommendations

Recent analyst recommendations indicate a maintenance of existing ratings, with no significant upgrades or downgrades, suggesting stability in market views on Henry Schein, Inc. The table below lists the latest analysis:

Date New Recommendation Last Recommendation Publisher
2025-11-05 Underweight Underweight Morgan Stanley
2025-11-05 Equal Weight Equal Weight Wells Fargo
2025-11-05 Overweight Overweight JP Morgan
2025-11-05 Outperform Outperform Evercore ISI Group
2025-11-05 Outperform Outperform Barrington Research

Analyst Recommendations with Change of Opinion

Over the months, some analysts have changed their views on Henry Schein, Inc., indicating occasional shifts in market perspectives. The adjustments showcase a mix of upgrades and downgrades in outlook for the company.

Date New Recommendation Last Recommendation Publisher
2025-08-26 Outperform In Line Evercore ISI Group
2025-07-25 Hold Buy Stifel
2025-07-14 Neutral Outperform Baird
2025-01-06 Buy Underperform B of A Securities
2024-07-22 Outperform Neutral Baird

Interpretation

The analysis of Henry Schein, Inc.'s stock ratings reveals a predominantly cautious stance among analysts, as reflected in the high 'Hold' scores. This sentiment suggests a conservative outlook with no major uptrends anticipated in the near term. There is a mixture of opinions, with some optimism showcased through upgrades, yet an underlying hesitance is prevalent. The minor increase in 'Strong Buy' points towards a potential upward reevaluation of the company's market performance. Overall, stability seems to characterize the analyst viewpoint, with confidence maintained at moderate levels.

Conclusion

Henry Schein, Inc. exhibits a stable but cautious analyst sentiment, underscored by the prevalence of 'Hold' ratings. The healthcare sector dynamics offer growth opportunities, but also present inherent challenges and uncertainties. Investors should weigh these factors meticulously. Recent upgrades indicate pockets of optimism, but substantial uplifts in stock price may require new catalysts. Continued observation of market trends, competitive positioning, and sectoral shifts is recommended for potential investors.